ILUVIEN, innovative pharmaceutical treatment for Diabetic Macular Edema, now available in Italy
03 February 2017
ILUVIEN®, exclusively marketed in Italy by SIFI, is now fully reimbursed as a hospital-administered therapy.
SIFI, the leading Italian ophthalmic company, is pleased to announce that ILUVIEN®, a novel treatment for diabetic macular edema,...
> read on